Skip to main content
. 2021 Jun 21;9(6):779. doi: 10.3390/healthcare9060779

Table 9.

Summary of studies that used NMDA antagonists to treat tinnitus.

Drug Authors Subjects Success Rate
Acamprosate Azevedo [66] 25 The beneficial effect increased from 1 month to 3 months
Caroverine Denk [63] 30 No improvement 11/30
1 point better 14/30
2 points better 4/30
3 points better 1/30
Domeisen [64] 24 Better 0/24
Unchanged 20/24
Worse 4/24
Memantine Figueiredo [65] 43 Worsening (THI 10) 9/43
Stable (−10 to 10) 18/43
Improvement (THI −10) 16/43
Neramexane Suckfüll [68] 317 Significantly better scores in the 50 mg/d group